Access cutting-edge obesity treatment through this clinical trial at a research site in Stamford. Study-provided care at no cost to qualified participants.
Access obesity specialists in Stamford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obesity treatment provided free
The main purpose of this study, performed under Master Protocol J4M-MC-PWMP, is to evaluate the efficacy, safety, and pharmacokinetics of orforglipron once daily oral versus Placebo in adolescent participants with obesity, or overweight with related comorbidities. Participation in the study will last about 18 months.
Sponsor: Eli Lilly and Company
Check if you qualify for this obesity clinical trial in Stamford, CT
If you're searching for obesity treatment options in Stamford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stamford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.